Cargando…
SUN-068 Clinical Validation Of A Novel Cardio-metabolic Diagnostic Technology
Hypercholesterolemia is a cardio-metabolic disease caused by a disruption in low density lipoprotein (LDL) cholesterol metabolism. Proprotein convertase subtilisin-kexin 9 (PCSK9) is an indirect regulator of plasma LDL levels by controlling the number of LDL receptor molecules expressed at the plasm...
Autores principales: | Melendez, Quantil, Wooten, Catherine, Lopez, Dayami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553021/ http://dx.doi.org/10.1210/js.2019-SUN-068 |
Ejemplares similares
-
SUN-574 A1AT: Novel Inhibitor of Active PCSK9
por: Melendez, Quantil, et al.
Publicado: (2020) -
Identification of Proteins Interacting with PCSK9 Using a Protoarray Human Protein Microarray
por: Wooten, Catherine J., et al.
Publicado: (2019) -
Identification of Novel Proteins Interacting with Proprotein Convertase Subtilisin/Kexin 9
por: Melendez, Quantil M., et al.
Publicado: (2020) -
PSUN300 The sex-specific correlation of IL7, high HbA1c and liver damage markers in African Americans
por: Webb, Kenisha, et al.
Publicado: (2022) -
SAT-068 A Precise Prevalence Of Genotypes And Histological Subtypes Of Consecutive JapanesePA CasesUndergoing Surgery From 2012 To 2017
por: Yamazaki, Yuto, et al.
Publicado: (2019)